Department of Orthopedic Surgery, Rehasport Clinic, Poznan, Poland.
Center for Advanced Technology, Adam Mickiewicz University in Poznan, Poznan, Poland.
Int Orthop. 2023 Oct;47(10):2409-2417. doi: 10.1007/s00264-023-05711-2. Epub 2023 Feb 11.
The functional outcomes of arthroscopic matrix-based meniscus repair (AMMR) in patients two and five years after the treatment clearly show that the use of the collagen matrix and bone marrow aspirate creates favorable biological conditions for meniscus healing. This study not only provides ten follow-up results but also investigates biomolecular mechanisms governing the regenerative process.
Case series was based on data collected from patients who underwent AMMR procedure, starting with preoperatively through two-year and five-year till ten-year follow-up. The outcomes are presented as IKDC and the Lysholm subjective scores as well as the imaging results. Biomolecular investigation of the membranes utilized in the AMMR procedure include DNA content analysis, cell viability and proliferation study of bone marrow and bone marrow concentrate-derived cells, and cytokine array performed on monocytes cultured on the membranes.
Data collected from patients who underwent AMMR procedure, starting with pre-operatively through two year and five year till ten year follow-up, indicate the possibility for long-term, stable meniscus preservation. Outcomes are manifested with a visible improvement of the IKDC and the Lysholm subjective scores as well as in the imaging results. The type of the meniscal tear or complexity of the knee injury (isolated AMMR vs. AMMR + ACL) did not affect the clinical outcomes. The study highlighted the role of the membrane in facilitating cell adhesion and proliferation. Additionally, several cytokines were selected as potentially crucial products of the membrane vs. monocyte interactions, driving the tissue regeneration and remodeling. Interestingly, thresholds of what constitutes a safe and well-decellularized membrane according to relevant literature have been significantly breached, but ultimately did not elicit detrimental side effects.
关节镜下基于基质的半月板修复(AMMR)治疗后 2 年和 5 年的功能结果清楚地表明,使用胶原基质和骨髓抽吸为半月板愈合创造了有利的生物学条件。本研究不仅提供了 10 项随访结果,还研究了控制再生过程的生物分子机制。
病例系列研究基于接受 AMMR 手术的患者的数据,从术前到两年和五年,直到十年的随访。结果以 IKDC 和 Lysholm 主观评分以及影像学结果表示。对 AMMR 手术中使用的膜进行生物分子研究,包括 DNA 含量分析、骨髓和骨髓浓缩物衍生细胞的细胞活力和增殖研究,以及在膜上培养的单核细胞进行细胞因子阵列分析。
从接受 AMMR 手术的患者(从术前到两年和五年,直到十年的随访)收集的数据表明,长期稳定的半月板保存是可能的。结果表现为 IKDC 和 Lysholm 主观评分以及影像学结果的明显改善。半月板撕裂的类型或膝关节损伤的复杂性(单纯 AMMR 与 AMMR+ACL)并不影响临床结果。该研究强调了膜在促进细胞黏附和增殖方面的作用。此外,选择了几种细胞因子作为膜与单核细胞相互作用的潜在关键产物,驱动组织再生和重塑。有趣的是,根据相关文献,安全且去细胞化的膜的阈值已经被显著突破,但最终没有产生有害的副作用。